| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/21/2002 | CA2422010A1 Test strips for detecting the presence of a reduced cofactor in a sample and methods for using the same |
| 03/21/2002 | CA2421994A1 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 03/21/2002 | CA2421963A1 Directed evolution method |
| 03/21/2002 | CA2421938A1 Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421747A1 Polymorphisms associated with cardiac arrythmia |
| 03/21/2002 | CA2421582A1 Combinatorial fluorescence energy transfer tags and uses thereof |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2419154A1 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 03/21/2002 | CA2418724A1 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | CA2391626A1 Combinatorial screening of mixed populations of organisms |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | CA2357549A1 Assay for identifying modulators of chondrogenesis |
| 03/20/2002 | EP1188841A1 Probe for constructing probe polymer, method of constructing probe polymer and utilization thereof |
| 03/20/2002 | EP1188840A2 Chemical reaction method and apparatus |
| 03/20/2002 | EP1188839A1 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
| 03/20/2002 | EP1188833A1 A method for producing plants which are resistant to closteroviruses |
| 03/20/2002 | EP1188056A1 Use of gabapentin in assays to identify gabab receptor modulators |
| 03/20/2002 | EP1188049A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand |
| 03/20/2002 | EP1188046A1 Electrochemical sensor for analysis of liquid samples |
| 03/20/2002 | EP1188042A1 Method and device for identifying a polymer |
| 03/20/2002 | EP1187939A2 Detection of hiv-1 by nucleic acid amplification |
| 03/20/2002 | EP1187937A1 Solid phase methods for amplifying multiple nucleic acids |
| 03/20/2002 | EP1187936A2 Automatable rapid test for detecting cancers, on the basis of telomerase(htc) mrna and specific primers and probes |
| 03/20/2002 | EP1187935A2 Methods for detection of nucleic acid polymorphisms using peptide-labeled oligonucleotides and antibody arrays |
| 03/20/2002 | EP1187934A1 Cell-based assay for screening cox-2 inhibitors |
| 03/20/2002 | EP1187933A1 Method and kit for detecting betalactam-containing compounds |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187928A2 Virus like particles, preparation and use in screening and functional genomics |
| 03/20/2002 | EP1187924A1 Substrate trapping protein tyrosine phosphatases |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187845A2 Tumor suppressor molecules and methods of use |
| 03/20/2002 | EP1187844A1 Human carbamyl phosphate synthetase i polymorphism and diagnostic and therapeutic methods relating thereto |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187678A1 Device for implementing an analysis pack, analysis pack and method using same |
| 03/20/2002 | EP1187620A1 Antisense modulation of b7 protein expression |
| 03/20/2002 | EP1187591A2 Ibd-associated microbial antigens and methods of using same |
| 03/20/2002 | EP1131629A4 Reagent composition and method for identification of reticulated cells |
| 03/20/2002 | EP1019842B1 Control of nucleic acid amplification procedures including the polymerase chain reaction (pcr) |
| 03/20/2002 | EP1006781A4 Soybean having epistatic genes affecting yield |
| 03/20/2002 | EP0963443A4 Releasable nonvolatile mass-label molecules |
| 03/20/2002 | EP0918786A4 Nuclease protection assays |
| 03/20/2002 | EP0915851B1 Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods |
| 03/20/2002 | EP0895546A4 Methods of isolating biological target materials using silica magnetic particles |
| 03/20/2002 | EP0871548B1 Reversibly, non-covalent bound surface coating |
| 03/20/2002 | EP0861332B1 A method of sequencing |
| 03/20/2002 | EP0819764B1 Use of o-beta-d-galactopyranosyl-d-xyloses for the preparation of compositions and solutions intended to the evaluation of intestinal lactase, and production process |
| 03/20/2002 | EP0801689A4 Method of screening for genetic predisposition to anticholinesterase therapy |
| 03/20/2002 | EP0787209B1 Method for amplifying nucleic acid sequences by displacement using chimeric primers |
| 03/20/2002 | EP0725682B1 Microfabricated, flowthrough porous apparatus |
| 03/20/2002 | EP0589961B1 Assay systems for neurotrophin activity |
| 03/20/2002 | CN1341212A Isolating cytoplasmic fraction without impairing viability of oocytes and embryonic cells |
| 03/20/2002 | CN1341210A Disposable test strips with integrated reagent/blood separation layer |
| 03/20/2002 | CN1341151A Herbicide target gene and methods |
| 03/20/2002 | CN1341147A Method for in vitro fertilisation of meiosis activating sterols (mas) |
| 03/20/2002 | CN1341118A Mitochondrial DNA damage as a predictor of coronary atherosclerotic heart disease |
| 03/20/2002 | CN1341004A Polarized light scattering spectroscopy of tissue |
| 03/20/2002 | CN1340706A Reagent kit and method for testing epidemic disease pathogen of prawn |
| 03/20/2002 | CN1340705A Method for detecting mutation of allelic gene point |
| 03/20/2002 | CN1340704A Application of vitrification technique in preparing enzyme-electrode test strip of electrochemical sensor for testing blood sugar |
| 03/20/2002 | CN1340624A Polypeptide-human cathepsin 10.12 and polynucleotide for coding it |
| 03/20/2002 | CN1340623A Polypeptide-glycosyl hydrolase 33.55 and polynucleotide for coding it |
| 03/20/2002 | CN1340622A Polypeptide-serine/threonine protein kinase MO1511.11 and polynucleotide for coding it |
| 03/20/2002 | CN1340621A Polypeptide-human casein kinase II alpha subunit 22.44 and polynucleotide for coding it |
| 03/20/2002 | CN1340620A Polypeptide-human phosphoryl choline/ethanolamine transferase 22.99 and polynucleotide for coding it |
| 03/20/2002 | CN1340619A Polypeptide-hydrogenase 9.13 and polynucleotide for coding it |
| 03/20/2002 | CN1340618A Polypeptide-nucleotide reductase 13.31 and polynucleotide for coding it |
| 03/20/2002 | CN1340617A Polypeptide-phosphoribosyl glycinamide synthetase 26.39 and polynucleotide for coding it |
| 03/20/2002 | CN1340616A Polypeptide-human fructose-6-phosphate, 2-kinase/fructose-2,6-diphosphatase 14.08 and polynucleotide for coding it |
| 03/20/2002 | CN1340615A Polypeptide-human uracil mononucleotide synthetase 42.79 and polynucleotide for coding it |
| 03/20/2002 | CN1081332C Preserving method for liquid diagnostic medicament and air-tight container |
| 03/19/2002 | US6359125 Process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 03/19/2002 | US6359124 Nucleotide sequences for use in the diagnosis, detection and treatment of arrhythmia, long q-t syndrome and cancers |
| 03/19/2002 | US6359116 Compounds |
| 03/19/2002 | US6358931 Oligonucletide conjugated to imidazole; intercalation and coordination compounds; medical diagnosis, gene therapy; antisense agents |
| 03/19/2002 | US6358923 Preventing and diagnosing blood, genetic, and nervous system disorders associated with decreased genetic expression |
| 03/19/2002 | US6358915 Administering uteroglobin as anticarcinogenic or antitumor agent to treat breast, lung or prostate cancer |
| 03/19/2002 | US6358752 Liposome-enhanced test device and method |
| 03/19/2002 | US6358742 Evolving conjugative transfer of DNA by recursive recombination |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/19/2002 | US6358728 Nucleotide sequences enzymatic polypeptide for use in treatment of vision defects |
| 03/19/2002 | US6358723 Deoxyribonuclease IIβ proteins and cDNAs |
| 03/19/2002 | US6358713 In vitro ribosome evolution |
| 03/19/2002 | US6358709 End selection in directed evolution |
| 03/19/2002 | US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis |
| 03/19/2002 | US6358704 M protein |
| 03/19/2002 | US6358701 A dna molecule encoding a protein; screening agonists and antagonsits; to determining channel modulators that may have insecticidal, mitacidal and/or nematocidal activity |
| 03/19/2002 | US6358700 Using fluorescent dye |
| 03/19/2002 | US6358699 Removing interfering components from sample, contacting with dimethylarginine dimethylamino-hydrolase to hydrolyze dimethylarginine to citrulline, spectrophotometrically determining citrulline |
| 03/19/2002 | US6358698 Determing antipsychotic activity of compounds by exposing a serotonin receptor having wild type activity with a test compound; then measure basal activity of the receptor; decreased activity indicates antipsychotic drug compound |
| 03/19/2002 | US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide |
| 03/19/2002 | US6358692 A multi-dimensional method for sreening binding affinities of ligands by mixing solutions of heterogenous ligands with targets of interest to form complexes that will then be separated by size exclusion chromatography |
| 03/19/2002 | US6358691 Target-dependent reactions using structure-bridging oligonucleotides |
| 03/19/2002 | US6358690 Determining shorter target dna sequences containing deletion mutations in a mixture of dna strands by polymerase chain reaction; the target sequences are selectively amplified over the full length sequences by limiting the extension time |
| 03/19/2002 | US6358689 Detection of markers in nascent proteins |
| 03/19/2002 | US6358687 Methods for monitoring the binding of A1/UP1 to single-stranded nucleic acid sequences, and to measure the effect of this binding on telomere extension and protection |